Oat6802
Payments companies reported to CMS as associated with Oat6802. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Oat6802, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Oat6802
These are the largest totals companies reported as associated with Oat6802. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Maurice Darvish | Los Angeles, CA | $22.75 | |
| Raphael Darvish | Los Angeles, CA | Internal Medicine | $22.75 |
| William Ziarnik | Tucson, AZ | Internal Medicine | $22.75 |
| James Jokerst | Kentwood, MI | Pediatrics | $15.46 |
| Dana Leary | Kentwood, MI | Pediatrics | $15.46 |
| Peter Vasiu | Grand Rapids, MI | Orthopaedic Surgery | $14.22 |
Prescribed Oat6802?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.